Distribution of single nucleotide polymorphisms related to paclitaxel and carboplatin toxicity in ovarian cancer patients

被引:0
|
作者
Cordova, Miguel
Bravo, Maria L.
Arriagada, Isidora
Cumsille, Elisa
Quinones, Luis
Bravo, Erasmo
Correa, Raimundo
Leiva, Juan E.
Paredes, Cesar
Cuello, Mauricio
Ibanez, Carolina
Garrido, Marcelo
Owen, Gareth I.
机构
关键词
D O I
10.1158/1538-7445.AM2017-5031
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5031
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Toxicity and compliance of first line carboplatin plus paclitaxel in elderly patients with ovarian cancer treated in a single center
    Aziz, M.
    Peschardt, K.
    Herrstedt, J.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2007, 64 : S35 - S35
  • [2] PACLITAXEL/CARBOPLATIN VERSUS SINGLE AGENT CARBOPLATIN IN PATIENTS WITH EPITHELIAL OVARIAN CANCER AND CORRELATION TO SERUM MARKER VEGF
    Malek, R. R. Abdel
    ANNALS OF ONCOLOGY, 2010, 21 : 309 - 309
  • [3] Paclitaxel with carboplatin for the treatment of ovarian cancer
    Neijt, JP
    Lund, B
    SEMINARS IN ONCOLOGY, 1996, 23 (06) : 2 - 4
  • [4] CARBOPLATIN AND PACLITAXEL IN OVARIAN-CANCER
    OZOLS, RF
    SEMINARS IN ONCOLOGY, 1995, 22 (03) : 78 - 83
  • [5] Paclitaxel sensitivity in relation to ABCB1 expression, efflux and single nucleotide polymorphisms in ovarian cancer
    Gao, Bo
    Russell, Amanda
    Beesley, Jonathan
    Chen, Xiao Qing
    Healey, Sue
    Henderson, Michelle
    Wong, Mark
    Emmanuel, Catherine
    Galletta, Laura
    Johnatty, Sharon E.
    Bowtell, David
    Haber, Michelle
    Norris, Murray
    Harnett, Paul
    Chenevix-Trench, Georgia
    Balleine, Rosemary L.
    deFazio, Anna
    SCIENTIFIC REPORTS, 2014, 4
  • [6] Paclitaxel sensitivity in relation to ABCB1 expression, efflux and single nucleotide polymorphisms in ovarian cancer
    Bo Gao
    Amanda Russell
    Jonathan Beesley
    Xiao Qing Chen
    Sue Healey
    Michelle Henderson
    Mark Wong
    Catherine Emmanuel
    Laura Galletta
    Sharon E. Johnatty
    David Bowtell
    Michelle Haber
    Murray Norris
    Paul Harnett
    Georgia Chenevix-Trench
    Rosemary L. Balleine
    Anna deFazio
    Scientific Reports, 4
  • [7] Carboplatin, cisplatin and paclitaxel in the treatment of patients with epithelial ovarian cancer
    De Placido, S
    Tramontana, S
    Ferrari, E
    De Matteis, A
    Lauria, R
    Perrone, F
    Bianco, AR
    Gallo, C
    Ricchi, P
    De Placido, G
    Pignata, S
    ANTICANCER RESEARCH, 2000, 20 (5C) : 4023 - 4029
  • [8] Single nucleotide polymorphisms in both endometriosis and ovarian cancer
    Kim, Tae-Hee
    Lee, Hae-Hyeog
    Hwang, Ji-Young
    Byun, Dongwon
    Mun, Myung Jin
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2014, 93 (08) : 839 - 841
  • [9] Feasibility, efficacy and toxicity of carboplatin and paclitaxel as a first-line treatment in elderly patients with ovarian cancer
    Kotani, N.
    Katsumata, N.
    Yonemori, K.
    Hirakawa, A.
    Yamamoto, H.
    Ono, M.
    Hirata, T.
    Yunokawa, M.
    Kouno, T.
    Shimizu, C.
    Tamura, K.
    Fujiwara, Y.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2009, 72 : S40 - S40
  • [10] Single-nucleotide polymorphisms associated with toxicity to radiotherapy in prostate cancer patients
    Spagnoletti, G.
    Frisani, P.
    Natalicchio, M.
    Enfasi, M.
    Cocco, G.
    Nardella, G.
    Plotino, G.
    Bove, G.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S627 - S627